| Symbol | Name | Industry | Sector | 1-Week
Relative Strength | 2-Week
Relative Strength | 4-Week
Relative Strength | 13-Week
Relative Strength | 26-Week
Relative Strength | 52-Week
Relative Strength | Last | Volume |
| |
GraniteShares 2x Long AAPL Daily Etf | Exchange Traded Fund | Financial Services Etf | 85 /100 | 79 /100 | 95 /100 | 91 /100 | 89 /100 | 80 /100 | 33.86 |
103,521 |
| |
Direxion Daily AAPL Bull 2X Shares | Exchange Traded Fund | Financial Services Etf | 86 /100 | 80 /100 | 95 /100 | 91 /100 | 89 /100 | 79 /100 | 36.52 |
1,579,915 |
| |
Abits Group Inc | Capital Markets | Financial Services | 92 /100 | 29 /100 | 85 /100 | 94 /100 | 91 /100 | 17 /100 | 6.41 |
13,467 |
| |
Arbutus Biopharma Corp | Biotechnology | Healthcare | 70 /100 | 35 /100 | 59 /100 | 90 /100 | 87 /100 | 81 /100 | 4.52 |
878,233 |
| |
Abivax S.A. ADR | Biotechnology | Healthcare | 90 /100 | 92 /100 | 95 /100 | 94 /100 | 100 /100 | 100 /100 | 110.39 |
2,417,023 |
| |
Achieve Life Sciences Inc | Biotechnology | Healthcare | 22 /100 | 18 /100 | 98 /100 | 96 /100 | 87 /100 | 37 /100 | 4.38 |
427,212 |
| |
AC Immune S.A. | Biotechnology | Healthcare | 47 /100 | 42 /100 | 91 /100 | 94 /100 | 93 /100 | 62 /100 | 3.29 |
155,074 |
| |
Aclaris Therapeutics Inc | Biotechnology | Healthcare | 94 /100 | 66 /100 | 96 /100 | 94 /100 | 93 /100 | 42 /100 | 2.52 |
2,242,846 |
| |
Acrivon Therapeutics Inc | Biotechnology | Healthcare | 98 /100 | 95 /100 | 95 /100 | 96 /100 | 94 /100 | 7 /100 | 2.24 |
1,184,410 |
| |
Adverum Biotechnologies Inc | Biotechnology | Healthcare | 42 /100 | 61 /100 | 32 /100 | 97 /100 | 94 /100 | 15 /100 | 4.29 |
211,117 |
|
Please sign up to view the complete list of stocks. |
|
|
NYSE
TSX
LSE
DUB
LIS
BME
PAR
AMS
BRU
XETRA
MIL
SIX
VIE
PRA
OSL
HEL
MOEX
TADAWUL
TLV
FDM
KUW
BSE
BM
SES
ISE
HKSE
SHSE
KRX
TSE
